ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, I.
Right arrow Articles by Wada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, I.
Right arrow Articles by Wada, M.
Related Collections
Right arrow Cerebral protection

Ann Thorac Surg 2002;74:2227-2228
© 2002 The Society of Thoracic Surgeons

Correspondence

Intraarterial thrombolysis for perioperative stroke in patients undergoing cardiac operations

Ikuo Fukuda, MDa, Mitsuyoshi Wada, MDb

a Department of Surgery 1, Hirosaki University School of Medicine 5 Zaifu-cho, Hirosaki, Aomori 036-8562, Japan
b Department of Radiology, Tsukuba Medical Center Hospital 1-3-1 Amakubo, Tsukuba, Ibaraki 305-8558, Japan

e-mail: ikuofuku@cc.hirosaki-u.ac.jp

The first 20% of the full text of this article appears below.

To the Editor:

We read with great interest the recent article by Dr Moazami and colleagues [1]. They reported successful outcome of intraarterial thrombolysis for an acute intracranial arterial occlusion after cardiac operation. Thrombolysis is an effective but potentially deleterious therapy and therefore, should be limited to patients with acute intracerebral vessel occlusion and salvageable tissue. The essential challenge of this approach for postcardiotomy stroke is adverse effects due to thrombolysis. Generally, major operation within the previous 14 to 30 days is considered a contraindication to fibrinolytic therapy because of incremental risk for surgical site bleeding. Hemorrhagic transformation of the infarction is another concern.

. . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.